Martin Sjöström Selected Research

Martin Sjöström Research Topics

22	Neoplasms (Cancer) 02/2022 - 05/2014
15	Breast Neoplasms (Breast Cancer) 01/2022 - 04/2013
11	Prostatic Neoplasms (Prostate Cancer) 01/2022 - 11/2017
4	Neoplasm Metastasis (Metastasis) 12/2020 - 01/2015
2	Urinary Bladder Neoplasms (Bladder Cancer) 02/2022 - 01/2021
2	Disease Progression 01/2022 - 01/2016
1	Carcinoma (Carcinomatosis) 02/2022
1	Hypoxia (Hypoxemia) 01/2022
1	Carcinogenesis 01/2022
1	Melanoma (Melanoma, Malignant) 12/2020
1	Lobular Carcinoma 06/2019
1	Lymphatic Metastasis 01/2015

8	Biomarkers (Surrogate Marker)IBA 09/2021 - 07/2015
7	Pharmaceutical PreparationsIBA 02/2022 - 01/2021
7	Estrogen ReceptorsIBA 01/2021 - 04/2013
5	Phenobarbital (Luminal)FDA Link 01/2022 - 10/2017
5	Proteins (Proteins, Gene)FDA Link 01/2021 - 01/2015
4	GTP-Binding Proteins (G-Protein)IBA 01/2020 - 04/2013
3	Androgen Receptors (Androgen Receptor)IBA 01/2022 - 06/2019
3	Tamoxifen FDA LinkGeneric 01/2020 - 04/2013
2	Immunoconjugates (Immunoconjugate)IBA 02/2022 - 01/2021
2	enfortumab vedotinIBA 02/2022 - 01/2021
2	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 11/2021
2	AndrogensIBA 01/2022 - 11/2021
2	AntigensIBA 01/2021 - 12/2020
2	Progesterone Receptors (Progesterone Receptor)IBA 06/2019 - 05/2014
1	sacituzumab govitecanIBA 02/2022
1	PanobinostatIBA 01/2022
1	Dasatinib (BMS 354825)FDA Link 01/2022
1	enzalutamideIBA 01/2022
1	Proto-Oncogene Proteins c-etsIBA 01/2022
1	Serine Proteases (Serine Protease)IBA 01/2022
1	AutoantibodiesIBA 12/2020
1	EpitopesIBA 12/2020
1	hydrogen sulfite (bisulfite)IBA 01/2020
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2020
1	Messenger RNA (mRNA)IBA 11/2017
1	ErbB Receptors (EGF Receptor)IBA 10/2017
1	Aldehyde DehydrogenaseIBA 12/2015
1	Peptides (Polypeptides)IBA 07/2015
1	ProteomeIBA 07/2015
1	GlycopeptidesIBA 07/2015
1	Glycoproteins (Glycoprotein)IBA 01/2015
1	Indicators and Reagents (Reagents)IBA 04/2013

8	Therapeutics 01/2022 - 01/2015
8	Radiotherapy 01/2022 - 10/2017
7	Segmental Mastectomy (Lumpectomy) 01/2022 - 10/2017
5	Castration 11/2021 - 11/2017
5	Adjuvant Radiotherapy 01/2021 - 10/2017
2	Immunotherapy 12/2020 - 01/2019
1	Aftercare (After-Treatment) 11/2021